CN113846034A - Lysobacter enzymogenes L-43 and application thereof - Google Patents
Lysobacter enzymogenes L-43 and application thereof Download PDFInfo
- Publication number
- CN113846034A CN113846034A CN202111255172.XA CN202111255172A CN113846034A CN 113846034 A CN113846034 A CN 113846034A CN 202111255172 A CN202111255172 A CN 202111255172A CN 113846034 A CN113846034 A CN 113846034A
- Authority
- CN
- China
- Prior art keywords
- lysobacter enzymogenes
- lysobacter
- fermentation
- enzymogenes
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000863030 Lysobacter enzymogenes Species 0.000 title claims abstract description 67
- 238000000855 fermentation Methods 0.000 claims abstract description 54
- 230000004151 fermentation Effects 0.000 claims abstract description 54
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims abstract description 42
- 241000894006 Bacteria Species 0.000 claims abstract description 26
- 238000004321 preservation Methods 0.000 claims abstract description 13
- 238000009920 food preservation Methods 0.000 claims abstract description 8
- 241001465754 Metazoa Species 0.000 claims abstract description 7
- 238000009395 breeding Methods 0.000 claims abstract description 6
- 230000001488 breeding effect Effects 0.000 claims abstract description 6
- 238000009629 microbiological culture Methods 0.000 claims abstract description 3
- 230000001580 bacterial effect Effects 0.000 claims description 17
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 12
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 12
- 230000012010 growth Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 241000191967 Staphylococcus aureus Species 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 241000193755 Bacillus cereus Species 0.000 claims description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical group [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000228245 Aspergillus niger Species 0.000 claims description 3
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 241000191938 Micrococcus luteus Species 0.000 claims description 3
- 241000223254 Rhodotorula mucilaginosa Species 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 241000186779 Listeria monocytogenes Species 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 239000012137 tryptone Substances 0.000 claims description 2
- 230000002538 fungal effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 244000005700 microbiome Species 0.000 abstract description 7
- 238000000926 separation method Methods 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 32
- 239000006228 supernatant Substances 0.000 description 21
- 239000000126 substance Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 15
- 230000003385 bacteriostatic effect Effects 0.000 description 13
- 241000863031 Lysobacter Species 0.000 description 11
- 241000792859 Enema Species 0.000 description 10
- 239000007920 enema Substances 0.000 description 10
- 230000003647 oxidation Effects 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 108091005804 Peptidases Proteins 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 7
- 239000004365 Protease Substances 0.000 description 7
- 229940095399 enema Drugs 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 230000002949 hemolytic effect Effects 0.000 description 7
- 235000019419 proteases Nutrition 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000001953 sensory effect Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000192125 Firmicutes Species 0.000 description 5
- 102000016943 Muramidase Human genes 0.000 description 5
- 108010014251 Muramidase Proteins 0.000 description 5
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229960000274 lysozyme Drugs 0.000 description 5
- 235000010335 lysozyme Nutrition 0.000 description 5
- 239000004325 lysozyme Substances 0.000 description 5
- 235000013580 sausages Nutrition 0.000 description 5
- 238000011161 development Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 102100023336 Chymotrypsin-like elastase family member 3B Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940079360 enema for constipation Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000006916 nutrient agar Substances 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 238000005554 pickling Methods 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 235000010241 potassium sorbate Nutrition 0.000 description 3
- 239000004302 potassium sorbate Substances 0.000 description 3
- 229940069338 potassium sorbate Drugs 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 230000003462 zymogenic effect Effects 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 2
- 102000012286 Chitinases Human genes 0.000 description 2
- 108010022172 Chitinases Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101000851141 Crotalus molossus nigrescens Snake venom metalloproteinase Proteins 0.000 description 2
- 241000192128 Gammaproteobacteria Species 0.000 description 2
- 238000003794 Gram staining Methods 0.000 description 2
- 101000907951 Homo sapiens Chymotrypsin-like elastase family member 3B Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000866438 Listeria monocytogenes 10403S Species 0.000 description 2
- 241001660189 Lysobacter antibioticus Species 0.000 description 2
- 238000013494 PH determination Methods 0.000 description 2
- 241000192142 Proteobacteria Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000589634 Xanthomonas Species 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000053197 Lysobacter gummosus Species 0.000 description 1
- 241000690807 Lysobacter sp. OC7 Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000947909 Xanthomonadales Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 244000000004 fungal plant pathogen Species 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000028744 lysogeny Effects 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010043524 protease E Proteins 0.000 description 1
- 238000002975 protease activity determination Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3571—Microorganisms; Enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a lysobacter enzymogenes L-43 and application thereof, wherein the lysobacter enzymogenes L-43 is preserved in China general microbiological culture Collection center of China Committee for culture Collection of microorganisms No. 3 of Navy No. 1 Hospital No. 3 in the south of Chaozhou, Beijing, 1 month and 5 days in 2021, and the preservation number is CGMCC NO. 21593; the bacteria can produce antibacterial peptide by fermentation. The method is suitable for separating the lysobacter enzymogenes L-43, the lysobacter enzymogenes L-43 obtained by separation can generate the antibacterial peptide, and the generated antibacterial peptide can be further applied to the fields of food preservation, animal nonreactive breeding and the like.
Description
Technical Field
The invention belongs to the field of bioengineering, and relates to a strain, in particular to lysobacter enzymogenes L-43 and application thereof.
Background
The microbial antibacterial substance has the characteristics of low toxicity, high efficiency, stability, no residue, short production period, low cost and the like, and is gradually a research hotspot in the fields of food, agriculture, medicine and the like; along with the rapid development of biotechnology, more and more natural antibacterial substances are produced by taking microorganisms and metabolites thereof as raw materials and utilizing technologies such as fermentation, extraction and the like;
at present, antibacterial substances from microorganisms have bioactivity on bacteria, fungi, viruses and even tumor cells, and are widely applied to various fields of food, agriculture, medical treatment and the like due to the characteristics of high stability, difficult generation of drug resistance, good inhibition effect and the like, so the development and application prospects are good; the microorganisms have huge groups in nature, can be fully excavated, and various strains with antibacterial properties are screened out from the groups, so that strain resources are provided for the development of novel antibacterial substances;
the lysobacter is Proteobacteria (Proteobacteria), Gamma-Proteobacteria (Gamma-Proteobacteria), Xanthomonas (Xanthomonadales), Xanthomonas (Xanthoonaceae); currently, about 50 kinds of reported Lysobacter bacteria are known, and four typical species among them are Lysobacter enzymogenes (Lysobacter enzymogenes), Lysobacter antibioticus (Lysobacter antibioticus), Lysobacter collodionalis (Lysobacter gummosus), and Lysobacter palmatus (Lysobacter palmescens), have high antibacterial activity and plant disease control potential, and are a new type of plant disease control bacteria; the bacteria have obvious antagonistic action on plant pathogenic fungi, oomycetes, gram-negative bacteria, positive bacteria and nematodes, and the action mechanism is as follows: (1) producing small molecule antibacterial secondary metabolites; (2) secretion to produce large amounts of extracellular enzymes including chitinase, beta-1, 3-glucan, protease and cellulase; (3) inducing plants to generate disease resistance; (4) better colonization ability;
in conclusion, the novel lysobacter strain with the bacteriostatic activity is separated and identified, so that a high-quality resource can be provided for the microbial antibacterial substance, and the novel lysobacter strain has great potential for developing novel, efficient and nontoxic natural medicines.
Disclosure of Invention
The invention aims to provide lysobacter enzymogenes L-43 so as to achieve the purposes of high growth speed, good adaptability and low fermentation cost, and the fermentation product can effectively resist gram-positive bacteria;
another object of the present invention is to provide the use of the above described lysobacter enzymogenes L-43.
In order to achieve the purpose, the invention adopts the technical scheme that:
the zymogenic bacillus L-43 is preserved in the common microbe center of China Committee for culture Collection of microorganisms, the preservation address is No. 3 of West Lu No. 1 of Beijing, sunward, the preservation date is 2021 year, 1 month and 5 days, the preservation number is CGMCC NO.21593, and the Latin literature name is Lysobacter enzymogens.
As a limitation, the 16SrRNA gene sequence of the lysobacter enzymogenes L-43 is as follows:
GGCTCAGAGTGAACGCTGGCGGCAGGCCTAACACATGCAAGTCGAACGGCAGCACAGAGGAGCTTGCTCCTTGGGTGGCGAGTGGCGGACGGGTGAGGAATACGTCGGAATCTGCCTATTTGTGGGGGATAACGTAGGGAAACTTACGCTAATACCGCATACGACCTACGGGTGAAAGTGGGGGACCTTCGGGCCTCACGCAGATAGATGAGCCGACGTCGGATTAGCTAGTTGGCGGGGTAAAGGCCCACCAAGGCGACGATCCGTAGCTGGTCTGAGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCCATGCCGCGTGTGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTTGTCCGGAAAGAAAAGCTTAGGGTTAATAACCCTGAGTCATGACGGTACCGGAAGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTACTCGGAATTACTGGGCGTAAAGCGTGCGTAGGTGGTTTGTTAAGTCTGATGTGAAAGCCCTGGGCTCAACCTGGGAATGGCATTGGAAACTGGCTTACTAGAGTGCGGTAGAGGGTAGCGGAATTCCCGGTGTAGCAGTGAAATGCGTAGATATCGGGAGGAACATCCGTGGCGAAGGCGGCTACCTGGACCAGCACTGACACTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGGGGGCAACTTGGCCCTCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGAAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGCAGAACCTTACCTGGCCTTGACATGTCGAGAACTTGGCAGAGATGCCTTGGTGCCTTCGGGAACTCGAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGGAACTCTAAGGAGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCAGGGCTACACACGTACTACAATGGTAGGGACAGAGGGCTGCAAACCCGCGAGGGCAAGCCAATCCCAGAAACCCTATCTCAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTTGCACCAGAAGCAGGTAGCTTAACCTTCGGGAGGGCGCTTGCCACGGTGTGGCCGATGACTGGGGTGAAGTCGT。
the invention also provides an application of the lysobacter enzymogenes L-43, and the lysobacter enzymogenes L-43 is used for food preservation or animal nonreactive breeding.
The present invention also provides another use of the above lysobacter enzymogenes L-43 for producing an antibacterial peptide by fermentation.
As a limitation, the fermentation comprises the following raw materials of effective components of a fermentation medium per 100g by weight: 0.5-2.0 parts of carbon source, 0.5-1.5 parts of nitrogen source, 0.05-0.15 part of inorganic salt and the balance of water.
As a further limitation, the carbon source is at least one of maltose, fructose, and liquid sugar; the nitrogen source is tryptone; the inorganic salt is magnesium sulfate or magnesium chloride.
As another limitation, the initial pH value of the fermentation is 6.0-7.0, the temperature is 30-32 ℃, the rotation speed is 180-.
The invention also provides an application of the antibacterial peptide, wherein the antibacterial peptide inhibits the growth of bacteria and fungi;
the bacteria are staphylococcus aureus, bacillus subtilis, bacillus cereus, listeria monocytogenes and micrococcus luteus;
the fungi are Aspergillus niger and Rhodotorula mucilaginosa.
As a limitation, the antimicrobial peptides are used for food preservation or antibiotic-free animal farming.
Due to the adoption of the technical scheme, compared with the prior art, the invention has the technical progress that:
the lysobacter enzymogenes L-43 obtained by the invention has the beneficial effects of fast growth, good adaptability and low fermentation cost;
secondly, the zymogenic lysobacter L-43 obtained by the invention has simple and easy operation fermentation method and improves the yield of the antibacterial peptide; the antibacterial peptide obtained by fermentation has broad-spectrum antibacterial property, can inhibit the growth of various bacteria and fungi, particularly shows excellent gram-positive bacteria resisting activity, and can well inhibit the growth of gram-positive bacteria;
the zymogenic lysobacter L-43 obtained by the invention is fermented to obtain the antibacterial peptide which is used as a substitute of antibiotics, can be used as a food preservative or a feed additive, is widely applied to the fields of food preservation, animal nonreactive breeding and the like, and has the characteristics of high efficiency and safety.
The method is suitable for separating the lysobacter enzymogenes L-43, the separated lysobacter enzymogenes L-43 can produce the antibacterial peptide through fermentation, and the produced antibacterial peptide can be further applied to the fields of food preservation, animal nonreactive breeding and the like.
Drawings
The invention will be described in more detail with reference to the following figures and embodiments:
FIG. 1 is a colony morphology on a plate of the strain of example 1 of the present invention;
FIG. 2 is a gram stain micrograph of the strain of example 1 of the present invention;
FIG. 3 is a phylogenetic tree of the strains according to example 1 of the present invention;
FIG. 4 is a graph showing the thermal stability of the L.enzymogenesis L-43 antibacterial substance in example 3 of the present invention;
FIG. 5 is a graph showing the pH stability of the L.enzymogenesis L-43 antibacterial substance in example 3 of the present invention;
FIG. 6 is a graph showing the storage stability of the L.enzymogenes L-43 antibacterial substance in example 3 of the present invention;
FIG. 7 is a diagram showing the fermentation process of L.enzymogenesis L-43 in the 5L fermenter for producing antibacterial peptide of example 10 of the present invention.
Detailed Description
The present invention is further illustrated by the following specific examples, which are to be construed as merely illustrative, and not limitative of the remainder of the disclosure.
Example 1 screening and identification of lysobacter enzymogenes L-43
First, strain information
The Lysobacter enzymogenes L-43 is separated and screened from soil, and its strain is preserved in China general microbiological culture Collection center at 1 month and 5 days of 2021, the preservation address is No. 3 of Xilu No. 1 of Beijing Korean district, the preservation number is CGMCC NO.21593, and the Latin name is Lysobacter enzymogenes.
Second, separation and screening method of lysobacter enzymogenes L-43
The separation and purification method is sequentially carried out according to the following steps:
s1, respectively collecting 40 soil samples from regions of Hebei and Jiangsu provinces, performing primary strain screening on a nutrient agar culture medium by adopting an Oxford cup agar diffusion method, respectively taking staphylococcus aureus and escherichia coli as indicator strains, taking the generated inhibition zone as a screening basis, and screening to obtain 45 strains capable of inhibiting the growth of the indicator strains, wherein the strains are respectively numbered from L-1 to L-45;
s2, culturing the primary screened strain in an LB (lysogeny broth) culture medium by taking bacillus cereus ATCC 11778, Listeria monocytogenes 10403s and Salmonella typhimurium ATCC 14028 as indicating strains, and respectively determining the bacteriostatic action of the primary screened strain L-1-L-45 fermentation supernatant on the indicating strains by adopting an oxford cup agar diffusion method by taking the bacteriostatic activity of the fermentation supernatant as a screening basis; 6 strains of the bacteria have good bacteriostatic effect; the serial numbers of the compounds are L-1, L-18, L-22, L-42, L-43 and L-45;
s3, further carrying out hemolytic experiment on the 6 screened bacteria and the fermentation supernatant thereof, observing hemolytic rings of the bacteria through a blood plate, and measuring hemolytic property of the fermentation supernatant through hemolytic rate, wherein the bacteria L-18, L-42 and L-43 are not hemolytic, and the hemolytic property of the fermentation supernatant of the bacteria L-43 is lowest;
s4, obtaining a bacterial strain L-43 with high antibacterial substance yield through screening, wherein the bacterial strain has a large inhibition zone on the indicator bacteria, particularly has the best inhibition capacity on gram-positive bacteria, and does not have hemolytic property.
Third, the identification of lysobacter enzymogenes L-43 strain
a1. And (3) morphological identification:
inoculating the strain L-43 screened in S3 to a nutrient agar plate, carrying out streak inversion culture in an incubator at 37 ℃, observing the edge characteristics, transparency, bulge shape, glossiness, color, morphology and size of a bacterial colony, carrying out gram staining, and observing the state under a microscope, wherein the morphology of the bacterial colony is shown in figure 1, wherein figure 1a is the morphology of the bacterial colony after 24h of culture, figure 1b is the morphology of the bacterial colony after 36h of culture, and figure 1c is the morphology of the bacterial colony after 48h of culture;
the gram stain results are shown in figure 2;
as can be seen from fig. 1: the bacterial colony of the strain L-43 on the nutrient agar plate has a large shape, the bacterial colony is in a round white sphere shape when cultured for 24 hours, the bacterial colony is in a yellowish color when cultured for 36 hours, which indicates that pigment is generated in the growth process, and the edge of the bacterial colony has a clear diffusion edge and a sliding movement phenomenon when cultured for 48 hours;
as can be seen from FIG. 2, the bacterial colony is purple after gram staining, and the bacterial strain L-43 is determined to be gram-negative bacteria, the thallus is in a fine rod shape and no spore is generated;
a2. and (3) molecular identification:
the molecular identification of the strain L-43 is entrusted to Shanghai bioengineering GmbH, and the 16SrDNA sequence of the strain L-43 has a full length of 1481bp through 16SrDNA sequence homology analysis of the strain, and the specific sequence is as follows:
GGCTCAGAGTGAACGCTGGCGGCAGGCCTAACACATGCAAGTCGAACGGCAGCACAGAGGAGCTTGCTCCTTGGGTGGCGAGTGGCGGACGGGTGAGGAATACGTCGGAATCTGCCTATTTGTGGGGGATAACGTAGGGAAACTTACGCTAATACCGCATACGACCTACGGGTGAAAGTGGGGGACCTTCGGGCCTCACGCAGATAGATGAGCCGACGTCGGATTAGCTAGTTGGCGGGGTAAAGGCCCACCAAGGCGACGATCCGTAGCTGGTCTGAGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCCATGCCGCGTGTGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTTGTCCGGAAAGAAAAGCTTAGGGTTAATAACCCTGAGTCATGACGGTACCGGAAGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTACTCGGAATTACTGGGCGTAAAGCGTGCGTAGGTGGTTTGTTAAGTCTGATGTGAAAGCCCTGGGCTCAACCTGGGAATGGCATTGGAAACTGGCTTACTAGAGTGCGGTAGAGGGTAGCGGAATTCCCGGTGTAGCAGTGAAATGCGTAGATATCGGGAGGAACATCCGTGGCGAAGGCGGCTACCTGGACCAGCACTGACACTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGGGGGCAACTTGGCCCTCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGAAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGCAGAACCTTACCTGGCCTTGACATGTCGAGAACTTGGCAGAGATGCCTTGGTGCCTTCGGGAACTCGAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGGAACTCTAAGGAGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCAGGGCTACACACGTACTACAATGGTAGGGACAGAGGGCTGCAAACCCGCGAGGGCAAGCCAATCCCAGAAACCCTATCTCAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTTGCACCAGAAGCAGGTAGCTTAACCTTCGGGAGGGCGCTTGCCACGGTGTGGCCGATGACTGGGGTGAAGTCGT
when the results of BLAST analyses and comparisons were performed using NCB I, as shown in Table 1, the selected strain L-43 showed the highest homology of 99.46% with Lysobacter enzymogenes M497-1 and Lysobacter sp.OC7, and the 16S rDNA sequence of the strain L-43 was uploaded to GeneBank to obtain the sequence number MT 229166;
table 116S rDNA sequence homology identification results
Constructing a growth and development tree of the strain L-43 according to the result, wherein the result is shown in FIG. 3, and the strain L-43 has the closest relationship with Lysobacter enzymogenes 521;the 16SrDNA sequence of the strain is compared with the standard strain of Lysobacter enzymogenes, and the result shows that the strain is compared with Lysobacter enzymogenes DSM2043T(AJ298291) having a homology of 99.19%, it was further confirmed that the strain L-43 belongs to Lysobacter enzymogenes, which was named Lysobacter enzymogenes L-43;
the strain is identified as Lysobacter enzymogenes by integrating the 16SrDNA sequence comparison result, physiological and biochemical characteristics and morphological characteristics of the strain, the strain is preserved in the common microorganism center of China Committee for culture Collection of microorganisms, the preservation address is No. 3 of West Lu No. 1 of Beijing Korean district, the preservation date is 2021 year, 1 month and 5 days, the preservation number is CGMCC No.21593, and the Latin is named as Lysobacter enzymogenes.
Example 2 verification of the antibacterial Effect of the antibacterial peptide produced by lysobacter enzymogenes L-43
The embodiment is a bacteriostatic effect verification experiment of antibacterial peptide produced by fermenting lysobacter enzymogenes L-43, and the specific method comprises the following steps: the antibacterial spectrum of the lysobacter enzymogenes antibacterial peptide is determined by adopting an agar diffusion method, the indicator bacteria mainly comprise common pathogenic bacteria and putrefactive fungi, the indicator bacteria comprise 5 strains of positive bacteria and 2 strains of fungi, and the specific indicator bacteria and the antibacterial effect are shown in table 2.
TABLE 2 bacteriostatic effect of antibacterial peptide produced by lysobacter enzymogenes L-43
Name of indicator bacterium | Diameter/mm of bacteriostatic circle |
Staphylococcus aureus ATCC 25923 | 17.45±0.55 |
Bacillus cereus ATCC 11778 | 14.55±0.30 |
Bacillus subtilis ATCC 6051 | 21.30±0.26 |
Listeria monocytogenes 10403s | 16.65±0.38 |
Micrococcus luteus ATCC 10240 | 18.93±0.78 |
Aspergillus niger ATCC 16404 | 13.20±0.13 |
Rhodotorula mucilaginosa | 14.15±0.13 |
As can be seen from Table 2, the antibacterial peptide produced by lysobacter enzymogenes L-43 can inhibit gram-positive bacteria and fungi, and has a wide antibacterial range and a good antibacterial effect.
EXAMPLE 3-8 fermentation method of lysobacter enzymogenes L-43
The embodiments 3 to 8 are fermentation methods of lysobacter enzymogenes L-43, respectively, and specifically include: weighing carbon source, nitrogen source, inorganic salt and distilled water according to the table 4, mixing uniformly, adjusting pH value, sterilizing at 121 ℃ for 20min to prepare a fermentation medium; inoculating lysobacter enzymogenes L-43 into a corresponding fermentation culture medium, and fermenting for 12-22h under the conditions that the temperature is 28-32 ℃, the rotating speed is 180-; they differ only in the raw materials, amounts, initial pH and process parameters, as detailed in table 3.
TABLE 3 fermentation Process parameters List for lysobacter enzymogenes producing antimicrobial peptides
In each embodiment, after fermentation is finished, fermentation liquor delta 1-delta 6 is obtained, the fermentation liquor delta 1-delta 6 is respectively centrifuged for 20min under the condition that the rotating speed is 8000r/min, supernate is collected, fermentation supernate epsilon 1-epsilon 6 is obtained, staphylococcus aureus ATCC 25923 is used as indicator bacteria, the yield of antibacterial peptide in the fermentation supernate epsilon 1-epsilon 6 is measured by a double dilution method, and the antibacterial titer is 364.5-4271.4 AU/mL.
EXAMPLE 9 characterization of the antimicrobial peptides produced by lysobacter enzymogenes L-43
This example is an experiment for identifying the chemical properties of the antibacterial peptide produced by lysobacter enzymogenes L-43, and the specific operations are as follows:
b1. enzyme Activity assay
Principle of enzyme activity assay: most lysobacters can secrete extracellular hydrolases, such as lysozyme, protease, chitinase, cellulase and the like, and the extracellular hydrolases achieve the bacteriostatic action by degrading the cell walls of indicator bacteria;
as can be known from an antibacterial spectrum experiment, antibacterial substances produced by the L.enzymogenes L-43 mainly inhibit bacteria, and on the basis, enzyme activities such as lysozyme and the like for hydrolyzing bacterial cell walls are mainly considered so as to analyze whether the L.enzymogenes L-43 produces hydrolase such as lysozyme, protease and the like;
through lysozyme activity determination and protease activity determination, the L.enzymogenes L-43 fermentation supernatant is found, namely lysozyme does not exist in the fermentation supernatant epsilon 1, and the protease activity is 199.73U/mL;
b2. protease treatment
Mixing L.enzymogenesis L-43 fermentation supernatant, the fermentation supernatant epsilon 1 and protease liquid in a volume ratio of 1:1, wherein the final concentration of protease is 10mg/mL, placing the mixture in a water bath kettle at 37 ℃ for reaction for 2h, treating the mixture with boiling water for 5min to terminate the enzyme reaction, and determining the recovery rate of the bacteriostatic activity by taking deionized water as a blank control, wherein the results are shown in Table 4;
wherein trypsin, proteinase K and proteinase E are solubilized with 0.1mol/L Tris-HCl buffer pH 7.5; dissolving pepsin with KCl-HCl buffer solution of 0.1mol/L, pH of 2.0; the catalase was dissolved in a phosphate buffer (0.2 mol/L, pH: 7.0);
TABLE 4 recovery of bacteriostatic activity of the fermentation supernatant ε 1 after enzyme treatment
Enzyme name | Percent recovery of bacteriostatic activity/%) |
Trypsin | 79.00±2.07 |
Pepsin | 77.05±2.65 |
Proteinase K | 78.74±0.45 |
Protease E | 73.43±1.13 |
|
100±0.96 |
As shown in table 4, the activities of the fermentation supernatant epsilon 1 are lost after being treated by trypsin, pepsin, proteinase K and proteinase E, which indicates that the antibacterial substance produced by l.enzymogenes L-43 is protein or polypeptide substance; no activity loss after catalase treatment, indicating that the fermentation supernatant contains no hydrogen peroxide; the chemical nature of the antibacterial substance in the fermentation supernatant epsilon 1 is mainly protein or polypeptide;
b3. heat resistance treatment
Heat treating the fermentation supernatant epsilon 1 in water bath pots at 40 deg.C, 60 deg.C, 80 deg.C and 100 deg.C for 30 min; treating the fermented supernatant with high pressure steam sterilizing pot at 121 deg.C for 20 min; respectively measuring the antibacterial activity, and taking the fermentation supernatant epsilon 1 which is not subjected to heat treatment as a reference;
the antibacterial activity recovery rate of the fermentation supernatant epsilon 1 after treatment at different temperatures is shown in fig. 4, and it can be seen that the antibacterial substance produced by L.enzymogenes L-43 has good thermal stability, more than 98% of antibacterial activity is still retained after treatment at 100 ℃ for 30min, and the activity recovery rate is 87.77% after treatment at 121 ℃ for 20 min; therefore, the antibacterial substance is a macromolecular protein, is less likely to be a polypeptide with good heat resistance;
b4. acid-base stability treatment
Taking 100ml of fermentation supernatant epsilon 2, dividing into 10 equal parts, respectively marking each 10ml as alpha 1-alpha 10, respectively adjusting the pH values to 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0 and 12.0 by using 0.1mol/L HCl and 0.1mol/L NaOH solutions respectively, carrying out water bath at 37 ℃ for 2h, then adjusting the pH values of the solutions back to the initial pH value of the fermentation liquor, namely 8.8, finally fixing the volume to 30ml, and measuring the bacteriostatic activity of the solution to investigate the stability of an antibacterial substance to acid and alkali, wherein the result is shown in figure 5;
as can be seen from FIG. 5, the activity recoveries were all maintained above 80% at pH 2-10, with 100% at pH 9, due analytically to pH 9 being closest to the initial broth pH of 8.8; when the pH value exceeds 11, the activity recovery rate is remarkably reduced, when the pH value is 12, the activity recovery rate is only 55.7 percent, and about half of the loss is achieved, so that the antibacterial substance produced by the L.enzymes L-43 is more stable in acidic and neutral environments compared with the alkaline environment;
b5. storage stability
Taking 100ml of fermentation supernatant epsilon 6, and measuring the bacteriostatic activity of the fermentation supernatant epsilon 6 after the fermentation supernatant epsilon 6 is stored for 30d, 60d, 90d, 120d, 160d and 180d at the temperature of 4 ℃, wherein the result is shown in figure 6;
as can be seen from fig. 6, the recovery rate of activity was maintained at 90% or more in 150d storage of the fermentation broth, and the recovery rate was decreased to about 87.32% after 180d storage, which indicates that the antibacterial substance had good storage stability.
EXAMPLE 10 fermentation tank experiment of lysobacter enzymogenes L-43
In this example, the results of an amplification experiment of antibacterial peptide by lysobacter enzymogenes L-43 in a 5L fermenter are shown in FIG. 7;
as can be seen from FIG. 7, in the process of producing the antimicrobial peptide by fermentation in the 5L fermentor, the content of the antimicrobial peptide is rapidly increased from 4h to reach the peak value of 3570.21AU/mL when reaching 12h, compared with the shake flask fermentation (2% of the inoculum size of lysobacter enzymogenes L-43 is inoculated in the fermentation medium, the fermentation is carried out at 32 ℃, 180r/min, and the maximum value of the peptide production is reached in 22 h), the fermentation time is greatly shortened.
EXAMPLE 11 Effect of antimicrobial peptides produced by lysobacter enzymogenes L-43 in food preservation
This example is an experiment of the effect of antibacterial peptide produced by lysobacter enzymogenes L-43 in enema preservation, and includes the following steps:
s1, self-made sausage without preservative:
taking 600g of fresh pork powder, adding 18g of refined salt, 6g of white sugar and 90mL of water, uniformly stirring, placing in a refrigerator for pickling for two hours (adding antibacterial peptide before pickling), adding 60g of corn starch, 30g of soybean protein powder, 1.8g of monosodium glutamate and 120mL of water after pickling, uniformly stirring, filling into four cellulose casings, steaming for 30 minutes, and then placing at room temperature for 30 minutes to obtain enema beta 1-beta 4, wherein beta 1 is a blank control group without the antibacterial peptide, beta 2 is a positive control group (according to the addition amount of 1 mg/g) with potassium sorbate, beta 3 is a low-dose experiment group with 240AU/mL of zymogen antibacterial peptide, and beta 4 is a high-dose experiment group with 600AU/mL of antibacterial peptide;
s2, storing the clysters beta 1-beta 4 in a sealed bag at the storage temperature of 25 ℃, randomly sampling and observing on days 0, 1, 2, 3, 4 and 5 respectively, and determining related indexes according to steps c1-c 4;
c1. determination of the Total number of colonies
Removing casings of the enemas beta 1-beta 4, putting the enemas beta 1-beta 4 into a homogenizing bag, kneading and crushing the enemas beta 1-beta 4, adding 0.85% of normal saline, beating and homogenizing for 2min under the condition that the rotating speed is 4000r/min, fully mixing the sample with the normal saline, preparing a sample theta 1-theta 4 for determining the total number of bacterial colonies, and determining the total number of the bacterial colonies in the theta 1-theta 4 according to the standard of GB 4789.2-2016;
c2. determination of fat Oxidation number
Filling a sausage beta 1-beta 4, removing casings, grinding, adding 7.5% trichloroacetic acid (containing 0.1% ethylene diamine tetraacetic acid), oscillating for 40min, performing suction filtration, adding 0.02 mol/L2-thiobarbituric acid solution, performing boiling water bath at 100 ℃ for 40min, cooling, centrifuging, taking supernate, adding chloroform, layering, taking supernate, performing colorimetry at the absorbance of 532nm and 600nm respectively, and recording the light absorption value;
the fat oxidation value is calculated as follows:
TBA=(A532-A600)/155×1/10×72.6×100
in the formula:
TBA value-fat oxidation number in mg/100 g;
a532-absorbance of sample at 532 nm;
a600-absorbance of sample at 600 nm;
c3. determination of pH
Grinding the sausage with casing removed, adding distilled water, and measuring pH value with pH meter;
c4. sensory evaluation of sausage
Inviting 10 experts to perform sensory evaluation on the enema beta 1-beta 4, wherein the evaluation standard is shown in the table 5;
TABLE 5 sensory evaluation of enema
The results of the measurement are as follows:
c1. determination of the Total number of colonies
After 5 days of determination, the total number of colonies of the group 1 and the group 2 control group is not obviously different, while the total number of colonies of the experimental group is lower than that of the control group, wherein the antibacterial effect of the antibacterial peptide (group 4) of the high-dose group is the best, and the total number of colonies is 1 Lg value lower than that of the group 1 and the group 2. Therefore, a certain amount of lysobacter enzymogenes antibacterial peptide can inhibit the growth of bacteria in pork, and the inhibition effect is more obvious when the addition amount of the antibacterial peptide is more;
c2. determination of fat Oxidation number
Fat oxidation number is an important indicator for assessing the freshness of meat products. The greater the fat oxidation number, the greater the degree of fat oxidation and the greater the degree of putrefaction of the enema. On day 1, the fat oxidation number was 0.316mg/100g for group 1, 0.098mg/100g for group 2, 0.161mg/100g for group 3, and 0.141mg/100g for group 4; on day 5, the fat oxidation values of groups 2, 3 and 4 were not significantly different, but were all significantly lower than group 1, 3-4 fold lower than group 1. Therefore, the putrefaction of the enema is effectively inhibited by adding the antibacterial peptide or the potassium sorbate;
c3. determination of pH
After 5 days of measurement, the pH value of the experimental group added with the antimicrobial peptide was lower than that of the control group as a whole. On day 0, the pH of groups 1-4 was around 6, on day 5, the pH of group 1 was the highest and the pH of group 4 was the lowest, 6.19, indicating that the appropriate amount of antimicrobial peptide inhibited microbial growth;
c4. sensory evaluation of sausage
The differences are shown on sensory evaluation of 3 days, wherein on color indexes, the antibacterial peptide experimental groups have uniform and small differences, and the color index of the antibacterial peptide experimental groups is 7.5, and the color index of the groups 1 and 2 is 5.5; in terms of odor, the antimicrobial peptide test group was slightly lower than those of groups 1 and 2; in the aspects of elasticity and viscosity, the group 1 has poor elasticity, is not easy to recover and sticks to hands after being pressed, and has 2 points, the group 2 and the antibacterial peptide experimental group have good elasticity, can recover after being pressed, slightly sticks to hands, and has a total score of 7 points;
the result shows that the adding of the lysobacter enzymogenes antibacterial peptide and the potassium sorbate in the enema can inhibit the growth and the propagation of microorganisms, and the oxidation degree of fat can influence the sensory evaluation.
SEQUENCE LISTING
<110> university of Hebei science and technology
<120> lysobacter enzymogenes L-43 and application thereof
<130> 1027
<160> 1
<170> PatentIn version 3.3
<210> 1
<211> 1481
<212> DNA
<213> Lysobacter enzymogenes L-43 (Lysobacter enzymogenes)
<400> 1
ggctcagagt gaacgctggc ggcaggccta acacatgcaa gtcgaacggc agcacagagg 60
agcttgctcc ttgggtggcg agtggcggac gggtgaggaa tacgtcggaa tctgcctatt 120
tgtgggggat aacgtaggga aacttacgct aataccgcat acgacctacg ggtgaaagtg 180
ggggaccttc gggcctcacg cagatagatg agccgacgtc ggattagcta gttggcgggg 240
taaaggccca ccaaggcgac gatccgtagc tggtctgaga ggatgatcag ccacactgga 300
actgagacac ggtccagact cctacgggag gcagcagtgg ggaatattgg acaatgggcg 360
caagcctgat ccagccatgc cgcgtgtgtg aagaaggcct tcgggttgta aagcactttt 420
gtccggaaag aaaagcttag ggttaataac cctgagtcat gacggtaccg gaagaataag 480
caccggctaa cttcgtgcca gcagccgcgg taatacgaag ggtgcaagcg ttactcggaa 540
ttactgggcg taaagcgtgc gtaggtggtt tgttaagtct gatgtgaaag ccctgggctc 600
aacctgggaa tggcattgga aactggctta ctagagtgcg gtagagggta gcggaattcc 660
cggtgtagca gtgaaatgcg tagatatcgg gaggaacatc cgtggcgaag gcggctacct 720
ggaccagcac tgacactgag gcacgaaagc gtggggagca aacaggatta gataccctgg 780
tagtccacgc cctaaacgat gcgaactgga tgttgggggc aacttggccc tcagtatcga 840
agctaacgcg ttaagttcgc cgcctgggaa gtacggtcgc aagactgaaa ctcaaaggaa 900
ttgacggggg cccgcacaag cggtggagta tgtggtttaa ttcgatgcaa cgcgcagaac 960
cttacctggc cttgacatgt cgagaacttg gcagagatgc cttggtgcct tcgggaactc 1020
gaacacaggt gctgcatggc tgtcgtcagc tcgtgtcgtg agatgttggg ttaagtcccg 1080
caacgagcgc aacccttgtc cttagttgcc agcacgtaat ggtgggaact ctaaggagac 1140
cgccggtgac aaaccggagg aaggtgggga tgacgtcaag tcatcatggc ccttacggcc 1200
agggctacac acgtactaca atggtaggga cagagggctg caaacccgcg agggcaagcc 1260
aatcccagaa accctatctc agtccggatt ggagtctgca actcgactcc atgaagtcgg 1320
aatcgctagt aatcgcagat cagcattgct gcggtgaata cgttcccggg ccttgtacac 1380
accgcccgtc acaccatggg agtttgttgc accagaagca ggtagcttaa ccttcgggag 1440
ggcgcttgcc acggtgtggc cgatgactgg ggtgaagtcg t 1481
Claims (9)
1. Lysobacter enzymogenes L-43, characterized in that: it is preserved in China general microbiological culture Collection center, the preservation address is No. 3 Xilu No. 1 Beijing, Chaoyang, the preservation date is 2021 year, 1 month and 5 days, the preservation number is CGMCC NO.21593, the Latin name isLysobacter enzymogenes。
2. The lysobacter enzymogenes L-43 according to claim 1, wherein: the 16SrRNA gene sequence is as follows:
GGCTCAGAGTGAACGCTGGCGGCAGGCCTAACACATGCAAGTCGAACGGCAGCACAGAGGAGCTTGCTCCTTGGGTGGCGAGTGGCGGACGGGTGAGGAATACGTCGGAATCTGCCTATTTGTGGGGGATAACGTAGGGAAACTTACGCTAATACCGCATACGACCTACGGGTGAAAGTGGGGGACCTTCGGGCCTCACGCAGATAGATGAGCCGACGTCGGATTAGCTAGTTGGCGGGGTAAAGGCCCACCAAGGCGACGATCCGTAGCTGGTCTGAGAGGATGATCAGCCACACTGGAACTGAGACACGGTCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGGACAATGGGCGCAAGCCTGATCCAGCCATGCCGCGTGTGTGAAGAAGGCCTTCGGGTTGTAAAGCACTTTTGTCCGGAAAGAAAAGCTTAGGGTTAATAACCCTGAGTCATGACGGTACCGGAAGAATAAGCACCGGCTAACTTCGTGCCAGCAGCCGCGGTAATACGAAGGGTGCAAGCGTTACTCGGAATTACTGGGCGTAAAGCGTGCGTAGGTGGTTTGTTAAGTCTGATGTGAAAGCCCTGGGCTCAACCTGGGAATGGCATTGGAAACTGGCTTACTAGAGTGCGGTAGAGGGTAGCGGAATTCCCGGTGTAGCAGTGAAATGCGTAGATATCGGGAGGAACATCCGTGGCGAAGGCGGCTACCTGGACCAGCACTGACACTGAGGCACGAAAGCGTGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCCCTAAACGATGCGAACTGGATGTTGGGGGCAACTTGGCCCTCAGTATCGAAGCTAACGCGTTAAGTTCGCCGCCTGGGAAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGTATGTGGTTTAATTCGATGCAACGCGCAGAACCTTACCTGGCCTTGACATGTCGAGAACTTGGCAGAGATGCCTTGGTGCCTTCGGGAACTCGAACACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGTCCTTAGTTGCCAGCACGTAATGGTGGGAACTCTAAGGAGACCGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAGTCATCATGGCCCTTACGGCCAGGGCTACACACGTACTACAATGGTAGGGACAGAGGGCTGCAAACCCGCGAGGGCAAGCCAATCCCAGAAACCCTATCTCAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGCAGATCAGCATTGCTGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTTGCACCAGAAGCAGGTAGCTTAACCTTCGGGAGGGCGCTTGCCACGGTGTGGCCGATGACTGGGGTGAAGTCGT。
3. the use of lysobacter enzymogenes L-43 according to claim 1 or 2, wherein: the lysobacter enzymogenes L-43 is used for food preservation or animal nonreactive breeding.
4. The use of lysobacter enzymogenes L-43 according to claim 1 or 2, wherein: the lysobacter enzymogenes L-43 is used for producing the antibacterial peptide by fermentation.
5. The use of lysobacter enzymogenes L-43 according to claim 4, wherein: the fermentation medium comprises the following raw materials in parts by weight per 100 g: 0.5-2.0 parts of carbon source, 0.5-1.5 parts of nitrogen source, 0.05-0.15 part of inorganic salt and the balance of water.
6. The use of lysobacter enzymogenes L-43 according to claim 5, wherein: the carbon source is at least one of maltose, fructose and liquid sugar;
the nitrogen source is tryptone; the inorganic salt is magnesium sulfate or magnesium chloride.
7. The use of lysobacter enzymogenes L-43 according to claim 4, wherein: the initial pH value of the fermentation is 6.0-7.0, the temperature is 30-32 ℃, the rotating speed is 180-.
8. A use of the antimicrobial peptide according to any one of claims 5 to 7, wherein: the antimicrobial peptides inhibit bacterial and fungal growth;
the bacteria are staphylococcus aureus, bacillus subtilis, bacillus cereus, listeria monocytogenes and micrococcus luteus;
the fungi are Aspergillus niger and Rhodotorula mucilaginosa.
9. The use of an antimicrobial peptide according to claim 8, wherein: the antibacterial peptide is used for food preservation or animal nonreactive breeding.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111255172.XA CN113846034B (en) | 2021-10-27 | 2021-10-27 | Lysobacter enzymogenes L-43 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111255172.XA CN113846034B (en) | 2021-10-27 | 2021-10-27 | Lysobacter enzymogenes L-43 and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113846034A true CN113846034A (en) | 2021-12-28 |
CN113846034B CN113846034B (en) | 2024-01-16 |
Family
ID=78983167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111255172.XA Active CN113846034B (en) | 2021-10-27 | 2021-10-27 | Lysobacter enzymogenes L-43 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113846034B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103408550A (en) * | 2013-07-11 | 2013-11-27 | 浙江工业大学 | 2,5-diketopiperazine dipeptide derived from lysobacter enzymogenes as well as preparation method and application thereof |
CN106434439A (en) * | 2016-09-21 | 2017-02-22 | 云南农业大学 | Lysobacter enzymogenes 1-T-1-4 and application thereof |
CN107099484A (en) * | 2017-06-26 | 2017-08-29 | 西南大学 | One plant of molten bacillus of producing enzyme and its application |
WO2021073131A1 (en) * | 2019-10-16 | 2021-04-22 | 中国海洋大学 | Medicament for efficiently killing drug-resistant disease bacteria and application thereof in inhibiting drug-resistant disease bacteria |
CN112760267A (en) * | 2021-02-09 | 2021-05-07 | 中国农业科学院蔬菜花卉研究所 | Lysobacter enzymogenes CX06 for antagonizing xanthomonas campestris and application thereof |
-
2021
- 2021-10-27 CN CN202111255172.XA patent/CN113846034B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103408550A (en) * | 2013-07-11 | 2013-11-27 | 浙江工业大学 | 2,5-diketopiperazine dipeptide derived from lysobacter enzymogenes as well as preparation method and application thereof |
CN106434439A (en) * | 2016-09-21 | 2017-02-22 | 云南农业大学 | Lysobacter enzymogenes 1-T-1-4 and application thereof |
CN107099484A (en) * | 2017-06-26 | 2017-08-29 | 西南大学 | One plant of molten bacillus of producing enzyme and its application |
WO2021073131A1 (en) * | 2019-10-16 | 2021-04-22 | 中国海洋大学 | Medicament for efficiently killing drug-resistant disease bacteria and application thereof in inhibiting drug-resistant disease bacteria |
CN112760267A (en) * | 2021-02-09 | 2021-05-07 | 中国农业科学院蔬菜花卉研究所 | Lysobacter enzymogenes CX06 for antagonizing xanthomonas campestris and application thereof |
Non-Patent Citations (1)
Title |
---|
田原等: "副干酪乳杆菌L1的安全性及益生性评价", 《食品工业科技》, vol. 40, no. 12, pages 121 - 122 * |
Also Published As
Publication number | Publication date |
---|---|
CN113846034B (en) | 2024-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105018379B (en) | One plant of active lactobacillus plantarum of tool high anti-oxidation and its application | |
CN109337841B (en) | Bacillus subtilis BYS2 with efficient antibacterial performance | |
CN108611299B (en) | Lactobacillus plantarum for producing antibacterial peptide and application thereof | |
CN113980848B (en) | Pediococcus pentosaceus SBC5 and application thereof | |
CN110777089B (en) | Strain for high-yield nattokinase and method for preparing natto by using strain | |
CN102517235A (en) | Bacillus subtilis | |
CN110791460B (en) | Strain for inhibiting growth of aspergillus flavus and generation of toxin | |
CN114921385B (en) | Bacillus subtilis and application thereof in feed addition and antibiotic-free cultivation | |
CN112662599A (en) | Poultry source Bacillus belgii CL-4 and application thereof | |
CN105176856A (en) | Screening and culture method of lactobacillus sakei LZ217 and application thereof | |
CN113755367A (en) | Biocontrol bacterium for botrytis cinerea and application of biocontrol bacterium | |
CN108865927B (en) | Bacterial strain for low-temperature glycolysis of corn straw and fermentation culture method and application thereof | |
CN109112086B (en) | Bacillus siamensis and application thereof | |
CN102168053A (en) | Paenibacilluspolymyxa strain for coproduction of LI-F type antibiotic and dibutyl phthalate and application thereof | |
CN117070428B (en) | Application of bacillus subtilis BS-22 strain in improving cultivation environment | |
CN113980853A (en) | Lactococcus garvieae WBT0008 capable of producing lactic acid at high yield and application thereof | |
CN113846034B (en) | Lysobacter enzymogenes L-43 and application thereof | |
CN108841743B (en) | Cold region straw rotten bacterial strain and preparation method and application thereof | |
CN106591176B (en) | Lactobacillus pentosus and application thereof | |
CN113308419B (en) | Lactobacillus chaff for fermentation and application thereof | |
CN114854629A (en) | Lactobacillus plantarum C-37 and application thereof in fermenting corn germ meal | |
CN115772482A (en) | Multifunctional bacillus belgii, microbial inoculum and application thereof | |
CN111979157B (en) | Potato dry rot antagonistic bacterium JZ3-1-15 and application thereof | |
CN115093989A (en) | Streptococcus salivarius QS-20 with antioxidant activity and application thereof | |
CN113621539A (en) | Screening and application of enzyme-producing bacteriostatic bacillus subtilis with vomitoxin detoxification function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |